In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Fortress Biotech Inc (NASDAQ: FBIO) closed at $3.28 down -15.90% from its previous closing price of $3.9. In other words, the price has decreased by -$15.90 from its previous closing price. On the day, 2.62 million shares were traded. FBIO stock price reached its highest trading level at $3.85 during the session, while it also had its lowest trading level at $3.25.
Ratios:
For a deeper understanding of Fortress Biotech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.97 and its Current Ratio is at 2.19. In the meantime, Its Debt-to-Equity ratio is 1.22 whereas as Long-Term Debt/Eq ratio is at 1.08.
On August 04, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $6.
On October 02, 2020, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $9.The Benchmark Company initiated its Buy rating on October 02, 2020, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 29 ’25 when Fortress Biotech, Inc. sold 100,000 shares for $1.29 per share. The transaction valued at 129,000 led to the insider holds 6,122,249 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBIO now has a Market Capitalization of 101804432 and an Enterprise Value of 93205432. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.63 while its Price-to-Book (P/B) ratio in mrq is 1.82. Its current Enterprise Value per Revenue stands at 1.496 whereas that against EBITDA is -1.166.
Stock Price History:
The Beta on a monthly basis for FBIO is 1.44, which has changed by 1.0418849 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, FBIO has reached a high of $4.53, while it has fallen to a 52-week low of $1.33. The 50-Day Moving Average of the stock is 4.56%, while the 200-Day Moving Average is calculated to be 33.89%.
Shares Statistics:
For the past three months, FBIO has traded an average of 633.19K shares per day and 1624050 over the past ten days. A total of 31.01M shares are outstanding, with a floating share count of 24.74M. Insiders hold about 20.29% of the company’s shares, while institutions hold 14.43% stake in the company. Shares short for FBIO as of 1767139200 were 4045115 with a Short Ratio of 6.39, compared to 1764288000 on 3706394. Therefore, it implies a Short% of Shares Outstanding of 4045115 and a Short% of Float of 16.309999.
Earnings Estimates
The stock of Fortress Biotech Inc (FBIO) is currently being evaluated by 1.0 analysts who are actively contributing to its market rating. Analysts are recommending an EPS of between -$0.08 and -$0.08 for the fiscal current year, implying an average EPS of -$0.08. EPS for the following year is -$2.12, with 2.0 analysts recommending between -$0.6 and -$3.64.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $18.8M this quarter.It ranges from a high estimate of $18.8M to a low estimate of $18.8M. As of. The current estimate, Fortress Biotech Inc’s year-ago sales were $15.12M
A total of 1 analysts have provided revenue estimates for FBIO’s current fiscal year. The highest revenue estimate was $65.98M, while the lowest revenue estimate was $65.98M, resulting in an average revenue estimate of $65.98M. In the same quarter a year ago, actual revenue was $57.67MBased on 2 analysts’ estimates, the company’s revenue will be $109.53M in the next fiscal year. The high estimate is $110.8M and the low estimate is $108.25M.
